California Bill to Legalize Access to Multiple Psychedelics Approved by Second Senate Committee

A second committee in California’s Senate has given approval to a bill to legalize therapeutic access to a handful of psychedelic substances.

Mescaline (top left), DMT (top right), dried psilocybin mushrooms (bottom left), and MDMA (bottom right).

By a vote of 3 to 2, the Senate Health Committee has voted to pass Senate Bill 1012 Senate Business, Professions and Economic Development Committee voted 7 to 4 today to pass Senate Bill 1012, The Regulated Psychedelic Facilitators Act and the Regulated Psychedelic-Assisted Therapy Act.

The Senate Health Committee’s approval of the bill comes a week after the measure was passed through the  Senate Business, Professions and Economic Development Committee by a vote of 7 to 4. The bill now moves to the Senate Appropriations Committee, with approval sending it to the full Senate.

Under the proposed law, a system of licensed service centers would be established in which those 21 and older could have legal access, and could legally consume, a variety of psychedelic substances including psilocybin (“magic mushrooms”), mescaline, DMT and MDMA.

In October Governor Gavin Newsom vetoed a bill to legalize psychedelics. SB 1012 has been designed to avoid an additional veto by narrowing the scope of the proposal and taking a more moderate approach.

“Psychedelics, when used safely, can turn people’s lives around, and we owe it to Californians to make these substances accessible in a safe and secure context, under the supervision of a licensed professional,” says Senator Scott Weiner, the bill’s primary sponsor. “I thank the Business and Professions Committee for recognizing that need today.”

Under the proposed law, psychedelic facilitators would be required to undergo training and obtain a license from a board established as part of the California Department of Consumer Affairs (DCA). A “Division of Regulated Psychedelic-Assisted Therapy” would be established under the under the Business, Consumer Services, and Housing Agency, tasked with regulations for the new program.

The measure would require those participating in the program to submit to a health and safety screening. That said, no qualifying medical condition would be required.

The full text of this bill can be found by clicking here.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Study: Long-Acting Injectable CBD Shows Weeks-Long Presence in Calves, Suggesting Possible Use for Painful Farm Procedures

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Bacteria From Hemp Seed Oil Shown to Combat Botrytis, Offering a New Biocontrol Tool for Cannabis Growers

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Florida Senate Bill Would Allow Qualified Patients to Grow Cannabis at Home

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Oregon Appeal Could Set National Precedent for Adding Female Orgasmic Disorder to Medical Marijuana Programs

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

Utah Medical Cannabis Program Has Over 106,000 Active Patients, With Over $160 Million in Sales So Far in 2025

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

California: Coastal Sun Greenhouse Flower Products Recalled After Presence of Aspergillus niger

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Senator Blocks Sara Carter’s Nomination for White House Drug Czar After Procedural Dispute

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Kentucky’s First Medical Marijuana Sales Expected “Within the Next Couple of Weeks”, Says Governor

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Every Cannabis Bill Filed in U.S. Congress During the 2025-2026 Session

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Massachusetts Regulators Sets December 11 Final Vote on Cannabis Consumption Sites

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Numerous Signature Gathering Events Scheduled for Idaho’s Medical Cannabis Legalization Initiative

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

Study Finds Medical Cannabis Linked to Improvements in Fibromyalgia Symptoms, Including Improved Sleep, Anxiety, and Overall Wellness

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

U.S. Congress: RESPECT Resolution Introduced to Advance Equity in the Marijuana Industry

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

The Best Selling Cannabis Strains in Every Recreational State (as of December 2025)

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

CBD May Help Stabilize Brain Chemistry in People at High Risk for Psychosis, Study Finds

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Massachusetts Marijuana Sales Reach $147 Million in November, $1.66 Billion in 2025, as Prices Fall to New Record Low

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Chicago Council Committee Approves Ordinance to Restrict Hemp-Derived Cannabinoid Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales

Florida’s Medical Marijuana Market Tops $1.5 Billion in Sales Through November, With Flower Leading Nearly Half of All Sales